Ionis Pharmaceuticals Inc (IONS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$5.15B
EV to revenue ratio (TTM)
6.99
EV to ebitda
135.77
Financial Performance
Revenue (TTM)
$0.96B
Gross profit (TTM)
$0.03B
EBITDA
-$0.55B
Profitability
Operating margin (TTM)
-53.80%
Profit margin
-56.90%
Return on assets (TTM)
-11.90%
Return on equity (TTM)
-108.10%
Per Share Metrics
Revenue per share (TTM)
$5.83
EPS
-$3.35
Diluted EPS (TTM)
-$3.35
Book value
$3
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
90.91
PEG ratio
25.70
Price to sales ratio (TTM)
5.37
Price to book ratio (TTM)
14.90
Growth
Quarterly earnings growth (YoY)
54.90%
Quarterly revenue growth (YoY)
-43.70%
Analyst Sentiment
Strong buy
9
Buy
12
Hold
4
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.40